Shenzhen GTJA Investment Group
Overview
Shenzhen GTJA Investment Group is a private equity and venture capital firm that focuses on growth stage investments and buyout deals, primarily in the healthcare industry in China . The firm was established in March 2001 and has operation centers in Shenzhen, Shanghai, Beijing, Nanjing, and Hong Kong . They are committed to investing in medical and health enterprises .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Degron Therapeutics | May 2026 | Series A Extension | Co-investor |
| Infinity Neuro | Dec 2025 | Series A | Lead |
| BridGene Biosciences | Oct 2025 | Series B Extension | Co-investor |
| Beijing Rosenbot Technology Co., Ltd. | Jan 2025 | Series C | Co-investor |
| TowardPi (Beijing) Medical Technology Group Co., Ltd. | Jun 2024 | Series D | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Shenzhen GTJA Investment Group based?
Shenzhen GTJA Investment Group is headquartered in Shenzhen, Guangdong, China.
When was Shenzhen GTJA Investment Group founded?
Shenzhen GTJA Investment Group was founded in 2001.
How many portfolio companies does Shenzhen GTJA Investment Group have?
Shenzhen GTJA Investment Group has 26 portfolio companies in Caplight's dataset.
What are some companies in Shenzhen GTJA Investment Group's portfolio?
Recent investments visible on Caplight include Degron Therapeutics, Infinity Neuro, BridGene Biosciences, Beijing Rosenbot Technology Co., Ltd., TowardPi (Beijing) Medical Technology Group Co., Ltd..
What was Shenzhen GTJA Investment Group's most recent investment?
Shenzhen GTJA Investment Group's most recent investment on Caplight was in Degron Therapeutics in 2026.
What sectors does Shenzhen GTJA Investment Group focus on?
Shenzhen GTJA Investment Group focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Media, Entertainment & Gaming, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Shenzhen GTJA Investment Group focus on?
Shenzhen GTJA Investment Group typically invests at the Mid stage.
What is Shenzhen GTJA Investment Group's AUM?
Shenzhen GTJA Investment Group's assets under management are estimated between $1.0B and $10.0B.